ReviewExpert opinion on drug safety2023

Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma.

Karthik Nath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.